Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007.

@article{Karlowsky2012MultidrugresistantNA,
  title={Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007.},
  author={James A Karlowsky and George G Zhanel and Greg W Hammond and Ethan Rubinstein and John Wylie and Tim Du and Michael R. Mulvey and Michelle J. Alfa},
  journal={Journal of medical microbiology},
  year={2012},
  volume={61 Pt 5},
  pages={693-700}
}
The objective of the current study was to determine whether the antimicrobial susceptibility profile or genotype of hospital-acquired isolates of Clostridium difficile differed from isolates causing community-acquired disease. Five hundred diarrhoeal stool samples (one >2 ml sample per patient) from patients across Manitoba, Canada, in 2006-2007 that were reported as C. difficile toxin positive were cultured, resulting in 432 isolates of toxin-positive C. difficile for analysis. Of these 432… CONTINUE READING